Emergent BioSolutions | EBS - Capitalización De Mercado

Precio De Mercado
9.50
Cambio Diario
0.37 4.05%
Mensual
12.43%
Anual
68.14%
Q2 Expectativa
8.94




Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 5.86B 14M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.69B 57M 2026-05
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Exelixis USD 12.68B 1.79B 2026-05
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Myriad Genetics USD 575M 98M 2025-12
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Neurocrine Biosciences USD 13.44B 189M 2026-05
Pacira USD 915M 149M 2026-03
Pfizer USD 149.77B 4.04B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12